Aptose Biosciences Inc (NASDAQ:APTO) has a beta value of 1.10 and has seen 1.12 million shares traded in the last trading session. The company, currently valued at $3.98M, closed the last trade at $0.18 per share which meant it lost -$0.01 on the day or -3.05% during that session. The APTO stock price is -1516.67% off its 52-week high price of $2.91 and 27.78% above the 52-week low of $0.13. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.52 million shares traded. The 3-month trading volume is 741.23K shares.
The consensus among analysts is that Aptose Biosciences Inc (APTO) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 3 have rated it as a Hold, with 3 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.35.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Aptose Biosciences Inc (NASDAQ:APTO) trade information
Sporting -3.05% in the red in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the APTO stock price touched $0.18 or saw a rise of 51.35%. Year-to-date, Aptose Biosciences Inc shares have moved -92.75%, while the 5-day performance has seen it change -46.45%. Over the past 30 days, the shares of Aptose Biosciences Inc (NASDAQ:APTO) have changed -52.48%. Short interest in the company has seen 0.12 million shares shorted with days to cover at 1.82.
Aptose Biosciences Inc (APTO) estimates and forecasts
Figures show that Aptose Biosciences Inc shares have outperformed across the wider relevant industry. The company’s shares have lost -83.90% over the past 6 months, with this year growth rate of 76.39%, compared to 18.00% for the industry. Revenue growth from the last financial year stood is estimated to be 0.00%.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 10.18% over the past 5 years.
APTO Dividends
Aptose Biosciences Inc is expected to release its next earnings report in December this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Aptose Biosciences Inc (NASDAQ:APTO)’s Major holders
Insiders own 15.87% of the company shares, while shares held by institutions stand at 16.68% with a share float percentage of 19.83%. Investors are also buoyed by the number of investors in a company, with Aptose Biosciences Inc having a total of 31.0 institutions that hold shares in the company. The top two institutional holders are DOHENY ASSET MANAGEMENT /CA with over 50550.0 shares worth more than $0.32 million. As of 2024-06-30, DOHENY ASSET MANAGEMENT /CA held 0.3849% of shares outstanding.
The other major institutional holder is CALDWELL SUTTER CAPITAL, INC., with the holding of over 92.0 shares as of 2024-06-30. The firm’s total holdings are worth over $70.0 and represent 0.0007% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Fidelity NASDAQ Composite Index Fund and DFA Investment Dimensions-Canadian Small Company Series . As of Sep 30, 2024 , the former fund manager holds about 0.01% shares in the company for having 2.16 shares of worth $398.0 while later fund manager owns 767.0 shares of worth $141.0 as of Jul 31, 2024 , which makes it owner of about 0.00% of company’s outstanding stock.
